SciELO - Scientific Electronic Library Online

 
vol.22 número3Compuestos orgánicos volátiles exhalados: ¿eficaces para detectar cáncer de mama?Dosis baja de nivolumab en melanoma mucoso metastásico: reporte de caso índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta mexicana de oncología

versión On-line ISSN 2565-005Xversión impresa ISSN 1665-9201

Resumen

TELLEZ-BANUELOS, Martha C. et al. Immunotherapy in prostate cancer: fundamentals and opportunities for its application in the clinic. Gac. mex. oncol. [online]. 2023, vol.22, n.3, pp.130-139.  Epub 29-Sep-2023. ISSN 2565-005X.  https://doi.org/10.24875/j.gamo.23000123.

Radiotherapy, androgen deprivation therapy, and chemotherapy are the mainstay of treatment for prostate cancer; however, resistance development significantly limits their efficacy. Chronic inflammation has a major role in the process of carcinogenesis, and there is a suppression of immune response in prostate cancer. Thereby, immunotherapy represents a promising therapeutic tool as it can potentiate the immune response against the tumor. Multiple clinical trials evaluate the efficacy and utility of immunotherapy in this cancer, which will be discussed in this review.

Palabras llave : Prostatic neoplasms; Immunotherapy; Immunology.

        · resumen en Español     · texto en Español